SOX4 is a potential prognostic factor in human cancers: a systematic review and meta-analysis
Clin. transl. oncol. (Print)
; 18(1): 65-72, ene. 2016. tab, ilus
Article
in English
| IBECS
| ID: ibc-148053
Responsible library:
ES1.1
Localization: BNCS
ABSTRACT
Objective. The aim of the this study was to analyze the status of sex-determining region Y-related high-mobility group box 4 (SOX4) expression in varied human cancers and its correlation with overall survival in patients with human cancers. Methods. To observe initially the expression status of SOX4 in twenty kinds of human cancers at protein database (The Human Protein Atlas). We systematically and carefully searched the studies from electronic databases and seriously identified according to eligibility criteria. The correlation between SOX4 expression and overall survival in human cancers was evaluated through Review Manager. Results. We found that SOX4 expression was significantly positive in most types of human cancer tissues, and the positive rate of SOX4 expression was about 78 % in overall cancer tissues. Furthermore, a total of 10 studies which included 1348 cancer patients were included in the final analysis. Meta-analysis showed that SOX4 overexpression was correlated with a poor overall survival and the pooled hazard ratio (HR), and corresponding 95 % confidence interval (CI) was 1.67 (95 % CI 1.01-2.78). From subgroup analyses, we present evidence that SOX4 overexpression was an unfavorable prognostic factor for colorectal cancer patients recurrence-free survival and gastric cancer patients overall survival, and the pooled HRs (95 % CI) were 1.73 (95 % CI 1.04-2.88) and 3.74 (95 % CI 1.04-13.45), respectively. Conclusions. In summary, SOX4 is a potential prognostic biomarker in human cancers (AU)
RESUMEN
No disponible
Search on Google
Collection:
National databases
/
Spain
Database:
IBECS
Main subject:
Carcinoid Tumor
/
Colorectal Neoplasms
/
Uterine Cervical Neoplasms
/
Databases as Topic
/
SOX Transcription Factors
/
Liver Neoplasms
/
Neoplasms
Type of study:
Diagnostic study
/
Prognostic study
/
Systematic review
Limits:
Female
/
Humans
/
Male
Language:
English
Journal:
Clin. transl. oncol. (Print)
Year:
2016
Document type:
Article
Institution/Affiliation country:
The Jiaotong Hospital of Shanxi Province/China
/
The Tumor Hospital of Shanxi Province/China